Healthcare -
Biotechnology - NYSE - DK
$ 85.25
-0.105 %
$ 372 B
Market Cap
28.8
P/E
NVO - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss NVO - Novo Nordisk A/S
1.28 B
LAST VALUE
65.66%
2 YEAR CAGR
21.28%
5 YEAR CAGR
3.52%
10 YEAR CAGR